In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
Transcript
What larger initiatives are in place to address physician satisfaction and what do they hope to achieve?
In terms of large initiatives, in the last few years there’s been a real surge in interest in professional satisfaction in clinicians, physicians, and other types of clinicians as well. The American Medical Association, for example, has some efforts in place that are freely available to physician practices around the country. And these are general ideas on how to restructure in your practice to make it more durable basically.
There are also some what I call symptomatic treatments that have become popular like mindfulness training and other things that sort of like treat the symptom but not the cause. So like bringing tea or snacks around to people to make them feel appreciated in the practice. I do worry about that second category of popular approaches to professional satisfaction. The ones that are like mindfulness and the tea and you know appreciation letters. Those might be a cover up of underlying problems and you might be able to get a little bit of improvement in professional satisfaction without addressing any of the underlying issues and I do worry that that wouldn’t be a very good approach for people to take if on the other hand they could be addressing some underlying issues and getting a bump in professional satisfaction instead.
AI, GLP-1s Among Topics to Be Discussed During ASPC Annual Meeting
July 28th 2025The American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease Prevention features multiple sessions on different methods of treating and preventing cardiovascular disease, including through the use of artificial intelligence (AI) and glucagon-like peptide-1 (GLP-1) receptor agonists.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD
July 25th 2025A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).
Read More